folpet has been researched along with Cancer of Intestines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhat, VS; Cohen, SM; Cullen, JM; Gordon, EB; Harris, MA; Proctor, DM; Thompson, CM; Wood, CE | 1 |
| Arce, GT; Cohen, SM; Gordon, EB; Nyska, A; Singh, P | 1 |
2 review(s) available for folpet and Cancer of Intestines
| Article | Year |
|---|---|
An adverse outcome pathway for small intestinal tumors in mice involving chronic cytotoxicity and regenerative hyperplasia: a case study with hexavalent chromium, captan, and folpet.
Topics: Adverse Outcome Pathways; Animals; Captan; Chromium; Duodenum; Fungicides, Industrial; Humans; Hyperplasia; Intestinal Neoplasms; Mice; Phthalimides; Risk Assessment | 2020 |
Carcinogenic mode of action of folpet in mice and evaluation of its relevance to humans.
Topics: Animals; Carcinogenicity Tests; Carcinogens; Cell Proliferation; Dogs; Duodenum; Fungicides, Industrial; Humans; Intestinal Neoplasms; Mice; Phthalimides; Rats; Regeneration; Risk Assessment | 2010 |